NCT07509593

Brief Summary

This study aims to compare two commonly used radiofrequency ablation (RFA) techniques for the treatment of chronic tailbone (coccyx) pain, also known as coccydynia. Chronic coccydynia can significantly impair daily activities and reduce quality of life, particularly in patients who do not respond adequately to conservative treatments. Participants in this study will be randomly assigned to receive either a single-level or double-level radiofrequency ablation (RFA) procedure targeting the coccygeal nerve pathways. These procedures are minimally invasive and are routinely performed in pain management practice. The primary objective of the study is to determine which technique provides superior pain relief and functional improvement. Patients will be followed for up to two months after the procedure, and pain intensity and quality of life will be evaluated using validated outcome measures. The results of this study may help optimize interventional treatment strategies for patients suffering from chronic coccydynia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jun 2026Nov 2027

First Submitted

Initial submission to the registry

March 29, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 3, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

July 9, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

March 29, 2026

Last Update Submit

July 7, 2026

Conditions

Keywords

Chronic coccydyniaGanglion imparRadiofrequency ablationInterventional pain management

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity (Numeric Rating Scale, NRS)

    Pain intensity will be assessed using the Numeric Rating Scale (NRS), a self-reported scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain scores from baseline will be evaluated at 1 hour, 3 weeks, and 2 months after the procedure. Higher scores indicate worse pain intensity.

    Baseline, 1 hour, 3 weeks, and 2 months post-procedure

Secondary Outcomes (2)

  • Quality of life (EuroQol-5D-3L, EQ-5D-3L)

    Baseline, 3 weeks, and 2 months post-procedure

  • Functional status (Paris Coccydynia Questionnaire)

    Baseline, 3 weeks, and 2 months post-procedure

Study Arms (2)

Single-Level Radiofrequency Ablation

ACTIVE COMPARATOR

Participants in this arm will undergo fluoroscopy-guided single-level radiofrequency ablation of the ganglion impar using a standardized technique. The procedure will be performed under sterile conditions by experienced pain specialists.

Procedure: Single-Level Ganglion Impar Radiofrequency Ablation

Double-Level Radiofrequency Ablation

ACTIVE COMPARATOR

Participants in this arm will undergo fluoroscopy-guided double-level radiofrequency ablation of the ganglion impar, targeting two adjacent levels using a standardized technique. The procedure will be performed under sterile conditions by experienced pain specialists.

Procedure: Double-Level Ganglion Impar Radiofrequency Ablation

Interventions

Fluoroscopy-guided radiofrequency ablation of the ganglion impar will be performed using a transsacrococcygeal approach. After appropriate needle placement and confirmation, thermal radiofrequency lesioning will be applied at a single level using standardized parameters.

Single-Level Radiofrequency Ablation

Fluoroscopy-guided radiofrequency ablation of the ganglion impar will be performed using a combined transsacrococcygeal and transcoccygeal approach. After appropriate needle placement and confirmation, thermal radiofrequency lesioning will be applied at two adjacent levels using standardized parameters.

Double-Level Radiofrequency Ablation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with coccygeal pain lasting longer than 2 months
  • Patients who experienced significant pain relief (≥50% reduction) after a ganglion impar block performed within the last 6 months, but whose pain has subsequently recurred
  • Patients who provide informed consent to participate in the study

You may not qualify if:

  • Acute coccydynia (pain duration less than 2 months)
  • Patients who did not achieve significant benefit (\<50% pain reduction) from prior ganglion impar block
  • Patients with severe neurological or psychiatric disorders that impair communication or ability to follow instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Faculty of Medicine

Istanbul, PENDİK, 34899, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Gaye Boztepe, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups: single-level or double-level radiofrequency ablation of the ganglion impar. Each participant will receive only one assigned intervention, and outcomes will be assessed and compared between groups over the follow-up period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD

Study Record Dates

First Submitted

March 29, 2026

First Posted

April 3, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

July 9, 2026

Record last verified: 2026-07

Locations